The effect of preservative-free HP-Guar on dry eye after phacoemulsification: A flow cytometric study

Eye

Volumn 24, Issue 8, 2010, Pages 1331-1337

  Sanchez M A ^a   Arriola Villalobos, P ^a   Torralbo Jimenez P ^b   Giron N ^c   De La Heras, B ^c   Herrero Vanrell, R ^c   Lvarez Barrientos, A ^b   Benitez Del Castillo J M ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Projech Science to Technology   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

cataract surgery; dry eye; HP Guar; inflammation; phacoemulsification

Indexed keywords

ARTIFICIAL TEAR; CD11B ANTIGEN; CD3 ANTIGEN; DEXAMETHASONE PLUS TOBRAMYCIN; GUAR GUM; HLA DR ANTIGEN; HYDROXYPROPYL GUAR; UNCLASSIFIED DRUG;

AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; CYTOLOGY; DRY EYE; FEMALE; FLOW CYTOMETRY; GUAR; HUMAN; MALE; PHACOEMULSIFICATION; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; VISION;

EID: 77955651060     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.24     Document Type: Article

References (37)

1. Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among elderly. Am J Ophthalmol 1997; 124: 723-728.
2. Baudouin C, Haouat N, Brignole F, Bayle J, Gastaud P. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol 1992; 76: 545-549.
3. Mircheff AK, Wood RL, Gierow JP. Traffic of major histocompatibility complex class II molecules in rabbit lacrimal gland acinar cells. Invest Ophthalmol Vis Sci 1994; 35: 3943-3953.
4. Tsubota K, Fukagawa K, Fujihara T, Shimmura S, Saito I, Saito K et al. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest Ophthalmol Vis Sci 1999; 40: 28-34.
5. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci 1997; 8: 1458-1464.
6. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5: 75-92.
7. Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002; 133: 181-186. (Pubitemid 34072045)
8. Liu Z, Pflugfelder S. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999; 106: 939-943.
9. Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology 2003; 110: 1412-1419.
10. Liu Z, Luo L, Zhang Z, Cheng B, Zheng D, Chen W et al. Tear film changes after phacoemulsification. Zhonghua Yan Ke Za Zhi 2002; 38: 2747.
11. Liu X, Yang-Shun GU, Ye-Sheng XU. Changes of tear film and tear secretion after phacoemulsification in diabetic patients. J Zhejiang Univ Sci B 2008; 9: 324-328. (Pubitemid 351486358)
12. Li XM, Hu L, Hu J, Wang W. Investigation of dry eye disease and analysis of the phatogenic factors in patients after cataract surgery. Cornea 2007; 26: S16-S20.
13. Ousler GW, Michaelson C, Christensen MT. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops. Cornea 2007; 26: 949-952.
14. Christensen MT. Corneal staining reductions observed after treatment with Systane lubricant eye drops. Adv Ther 2008; 25: 1191-1199.
15. Cervan-Lopez I, Saenz-Frances-San-Baldomero F, Benitez-del-Castillo JM, Garcia-Sanchez J. Reduction of corneal permeability in patients treated with HP-Guar: A fluorophotometric study. Arch Soc Esp Oftalmol 2006; 81: 327-332.
16. Brignole-Baudouin F, Ott AC,Warnet JM, Baudouin C. Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies. Exp Eye Res 2004; 78: 473-481.
17. Brignole F, de Saint-Jean M, Goldschild M, Becqet F, Goguel A, Baudouin C. Expression of Fas-Fas ligand antigens and apoptotic marker APO2-7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res 1998; 67: 687-697.
18. Pisella PJ, Brignole F, Debbasch C, Lozat P, Garcher C, Bara J et al. Flow cytometric analysis of conjunctival epithelium in occular rosacea and keratoconjunctivitis sicca. Ophthalmology 2000; 107: 1841-1849.
19. Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 2001; 112: 1446-1454.
20. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003; 22: 640-650.
21. Vico E, Benítez del Castillo JM, Jiménez RA, Fernández C, García Sánchez J. Tear function index validation for dry eye diagnosis. Arch Soc Esp Oftalmol 2004; 79: 265-271.
22. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of ocular surface disease index. Arch Ophthalmol 2001; 119: 456.
23. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998; 17: 584-589.
24. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000; 41: 1356-1363.
25. Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC et al. Conjunctival T-cell subpopulations in Sjögrens and non-Sjögrens patients with dry eye. Invest Ophthalmol Vis Sci 2002; 43: 2609-2614.
26. Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol 2000; 118: 1489-1496.
27. Montés-Micó R. Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg 2007; 33: 1631-1635.
28. Liu Z, Pflugfelder S. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999; 106: 939-943.
29. Nilforoushan MR, Latkany RA, Speaker MG. Effect of artificial tears on visual acuity. Am J Ophthalmol 2005; 140: 830-835.
30. Khanal S, Tomlison A, Esakowitz L, Bhatt P, Jones D, Nabili S et al. Changes in corneal sensitivity and tear physiology after phacoemulsification. Ophthal Physiol Opt 2008; 28: 127-134.
31. Kohlhaas M. Corneal sensation after cataract and refractive surgery. J Cataract Refract Surg 1998; 24: 1399-1409.
32. Ubels JL, Clousing DP, Van Haitsma TA, Hong BS, Stauffer P, Asgharian B et al. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent. Curr Eye Res 2004; 28: 437-444.
33. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008; 126: 219-225.
34. Roberts CW, Elie ER. Dry eye symptoms following cataract surgery. Insight 2007; 32: 14-21.
35. Fakhraie G, Lopes JF, Spaeth GL, Almodin J, Ichhpujani P, Moster MR. Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery. Clin Experiment Ophthalmol 2009; 37: 842-848.
36. Ram J, Gupta A, Brar GS, Kaushik S, Gupta A. Outcomes of phacoemulsification in patients with dry eye. J Cataract Refract Surg 2002; 28: 1386-1389.
37. Hardten DR. Dry eye disease in patients after cataract surgery. Cornea 2008; 27: 855.